Mar 5, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2023-N-5653-0033
AAM comments: FDA's Draft Report and Plan on Best Practices for Guidance
Association for Accessible Medicines filed 1 comment on this docket between Mar 5, 2024 and Mar 5, 2024. 3 other organizations filed here. The comment window closed 876d ago.
AAM comments: FDA's Draft Report and Plan on Best Practices for Guidance
Open
View on regulations.gov →